Sugentech is a leading brand in the global bioindustry, specializing in the development of bio/nano-based diagnosis and healthcare platforms. With a strong commitment to improving the health and well-being of humanity, Sugentech offers a range of innovative products and services. Their flagship product, SGTi-flex COVID-19 Ag, is a rapid antigen diagnostic kit for COVID-19.

It provides accurate and prompt results by detecting the presence of the coronavirus antigen in nasal swab samples, aiding in the diagnosis and management of COVID-19 infections. Sugentech is also recognized as a pioneer in immunological technology, particularly in the development of high-affinity antibodies and advanced immunodiagnostic methods. Their expertise extends to nanotechnology, utilizing optimized gold nanoparticles and fluorescent particles in the production of in vitro diagnostic products.

Driven by their comprehensive technology platform, Sugentech designs and manufactures multi-immunoblot automated systems for hospitals, point-of-care testing devices, and home testing kits. By integrating IT, mechanics, and design, they ensure the seamless integration of bio/nano-based reagents for accurate disease diagnosis. For over a decade, Sugentech has been at the forefront of R&D in the bioindustry, consistently delivering cutting-edge solutions that revolutionize healthcare and improve the lives of individuals worldwide